This Competitive Revision (NOT-OD-09-058;NIH Announces the Availability of Recovery Act Funds for Competitive Revision Applications) proposes to expand the scope of a currently funded project (R01DA023188) exploring the use of D-Cycloserine in facilitating extinction of response to cocaine-related cues by adding fMRI procedures (cocaine cue-induced BOLD fMRI, morphometric and volumetric MRI) before and after repeated trials of cocaine cue exposure. We hypothesize that there will be greater cocaine-cue induced activation in the prefrontal cortex, cingulate cortex, ventral striatum, amygdala and nucleus accumbens during the pre-extinction fMRI session as compared to the post-extinction fMRI session. Additionally, we hypothesize that there will be greater neutral-cue induced activation in the thalamus and amygdala during the post-extinction fMRI session as compared to the pre-extinction fMRI session. The addition of a BOLD fMRI component to this carefully controlled study of cocaine-cue extinction will accelerate and enhance the science of the parent proposal by allowing exploration of the neural circuitry activated in response to cocaine cues and alterations that occur after extinction of response to cocaine cues. Increased knowledge about neural processes involved in extinction could have clear therapeutic implications by providing empirical evidence to guide the search for therapeutic strategies which might be useful in reducing cue salience, facilitating cue extinction, or improving inhibitory control in cocaine-dependent individuals. Furthermore, the proposed project will provide economic stimulation by allowing for the hiring of additional staff for patient recruitment, protocol operation, and neuroimaging data analysis.

Public Health Relevance

Cocaine-related environmental cues are likely to be involved in relapse. This study will add neuroimaging to an ongoing study of a pharmacologic intervention that may decrease the response to cocaine cues. Knowledge of the brain circuitry involved in craving may be important for developing treatments for cocaine dependence.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
3R01DA023188-02S1
Application #
7811953
Study Section
Special Emphasis Panel (ZDA1-JXR-D (10))
Program Officer
Biswas, Jamie
Project Start
2009-09-30
Project End
2012-09-29
Budget Start
2009-09-30
Budget End
2012-09-29
Support Year
2
Fiscal Year
2009
Total Cost
$567,200
Indirect Cost
Name
Medical University of South Carolina
Department
Psychiatry
Type
Schools of Medicine
DUNS #
183710748
City
Charleston
State
SC
Country
United States
Zip Code
29425
Santa Ana, Elizabeth J; Prisciandaro, James J; Saladin, Michael E et al. (2015) D-cycloserine combined with cue exposure therapy fails to attenuate subjective and physiological craving in cocaine dependence. Am J Addict 24:217-24
Prisciandaro, James J; McRae-Clark, Aimee L; Myrick, Hugh et al. (2014) Brain activation to cocaine cues and motivation/treatment status. Addict Biol 19:240-9
Prisciandaro, James J; Joseph, Jane E; Myrick, Hugh et al. (2014) The relationship between years of cocaine use and brain activation to cocaine and response inhibition cues. Addiction 109:2062-70
Prisciandaro, James J; Myrick, Hugh; Henderson, Scott et al. (2013) Impact of DCS-facilitated cue exposure therapy on brain activation to cocaine cues in cocaine dependence. Drug Alcohol Depend 132:195-201
Price, Kimber L; Baker, Nathaniel L; McRae-Clark, Aimee L et al. (2013) A randomized, placebo-controlled laboratory study of the effects of D-cycloserine on craving in cocaine-dependent individuals. Psychopharmacology (Berl) 226:739-46
Prisciandaro, James J; Myrick, Hugh; Henderson, Scott et al. (2013) Prospective associations between brain activation to cocaine and no-go cues and cocaine relapse. Drug Alcohol Depend 131:44-9
Brady, Kathleen T; Gray, Kevin M; Tolliver, Bryan K (2011) Cognitive enhancers in the treatment of substance use disorders: clinical evidence. Pharmacol Biochem Behav 99:285-94